Cite Filings / URGN
Feed Companies Filings Check
Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Filings Financials Insiders Search text
All 584 Financials 120 Shareholder Meetings 9 Executive Compensation 104 Insider Trading 233 Beneficial Ownership Interest 92 Business Combinations 85 Public Offerings 36 Foreign Private Issuers 31 Mutual Funds and ETFs 8 Others 71
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-30
  3. DEF 14A Proxy Proxy Statement 2025-07-15
  4. DEF 14A Proxy Proxy Statement 2024-07-01
  5. DEF 14A Proxy Proxy Statement 2023-08-01
  6. DEF 14A Proxy Proxy Statement 2022-05-02
  7. DEF 14A Proxy Proxy Statement 2021-04-28
  8. DEF 14A Proxy Proxy Statement 2020-04-29
  9. DEF 14A Proxy Proxy Statement 2019-04-26

Page 1 of 1 · 8 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…